Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,895,804 papers from all fields of science
Search
Sign In
Create Free Account
Taurine Lithocholate
Known as:
Lithocholate, Taurine
, Taurolithocholate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Taurolithocholic Acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
P. Puri
,
K. Daita
,
+14 authors
A. Sanyal
Hepatology
2018
Corpus ID: 12627334
The histologic spectrum of nonalcoholic fatty liver disease (NAFLD) includes fatty liver (NAFL) and steatohepatitis (NASH), which…
Expand
Highly Cited
2016
Highly Cited
2016
Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis
G. Xie
,
Xiaoning Wang
,
+11 authors
Wei Jia
International Journal of Cancer
2016
Corpus ID: 19704798
Dysregulated bile acids (BAs) are closely associated with liver diseases and attributed to altered gut microbiota. Here, we show…
Expand
Highly Cited
2015
Highly Cited
2015
Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors
Cheryl A. Brighton
,
J. Rievaj
,
+5 authors
F. Reimann
Endocrinology
2015
Corpus ID: 207068450
Bile acids are well-recognized stimuli of glucagon-like peptide-1 (GLP-1) secretion. This action has been attributed to…
Expand
Highly Cited
2004
Highly Cited
2004
Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3
H. Akita
,
Hiroshi Suzuki
,
T. Hirohashi
,
H. Takikawa
,
Y. Sugiyama
Pharmaceutical Research
2004
Corpus ID: 21857398
AbstractPurpose. Multidrug resistance-associated protein 3 (MRP3) was initially cloned as a hepatic transporter induced under…
Expand
Highly Cited
2003
Highly Cited
2003
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
N. Zelcer
,
G. Reid
,
+4 authors
P. Borst
Biochemical Journal
2003
Corpus ID: 9822734
Human multidrug-resistance protein (MRP) 4 transports cyclic nucleotides and when overproduced in mammalian cells mediates…
Expand
Highly Cited
1999
Highly Cited
1999
Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion.
G. Alpini
,
S. Glaser
,
+7 authors
G. Lesage
Gastroenterology
1999
Corpus ID: 24038007
Highly Cited
1989
Highly Cited
1989
Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions.
D. Heuman
Journal of Lipid Research
1989
Corpus ID: 21276871
This paper describes the derivation of a bile salt monomeric hydrophobicity index that quantitatively defines the composite…
Expand
Highly Cited
1984
Highly Cited
1984
Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles
J. Schölmerich
,
M. Becher
,
+4 authors
W. Gerok
Hepatology
1984
Corpus ID: 23316626
To characterize the relative toxicity of different bile salts, isolated hepatocytes were incubated with different concentrations…
Expand
Highly Cited
1971
Highly Cited
1971
Bile acid sulfates. I. Synthesis of lithocholic acid sulfates and their identification in human bile.
R. Palmer
,
M. Bolt
Journal of Lipid Research
1971
Corpus ID: 25561403
Sulfate esters of lithocholic, glycolithocholic, and taurolithocholic acids were synthesized using sulfur trioxide in pyridine…
Expand
Highly Cited
1966
Highly Cited
1966
Cholestasis in Rats induced by Taurolithocholate
N. Javitt
Nature
1966
Corpus ID: 806131
THE taurine conjugates of cholic and chenodeoxycholic acid1 are preponderant bile acids of murine bile. The systematic names of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE